Search for: "AstraZeneca Pharmaceuticals LP"
Results 21 - 40
of 116
Sort by Relevance
|
Sort by Date
13 Feb 2015, 12:00 pm
AstraZeneca LP et al. was filed under seal on behalf of the federal government in October 2010 by former AstraZeneca employees Paul DiMattia and F. [read post]
17 Nov 2014, 9:59 pm
AstraZeneca Pharmaceuticals LP et al. v. [read post]
13 Nov 2014, 5:00 am
Such vaccine litigation (Bexis’ first exposure to a pharmaceutical mass tort) was ultimately adjudged so inimical to the public health that Congress prohibited it. [read post]
26 Oct 2014, 9:17 pm
AstraZeneca Pharmaceuticals LP et al. v. [read post]
23 Jun 2014, 12:57 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
3 May 2014, 8:56 am
Merrell Dow Pharmaceuticals, Inc., 89 F.3d 594, 596-98 (9th Cir. 1996) (affirming exclusion of Dr. [read post]
8 Dec 2013, 8:02 pm
Kremers Urban Pharmaceuticals, Inc. et al. 3:13-cv-07299; filed December 3, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
13 Nov 2013, 9:14 pm
The '834 patent is directed to a sterile, pharmaceutically effective budesonide product, which is used to treat asthma in... [read post]
27 Oct 2013, 9:55 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals... [read post]
19 Sep 2013, 9:53 am
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
14 Aug 2013, 1:57 pm
Novartis Pharmaceuticals Corp., ___ F. [read post]
10 Sep 2012, 7:28 pm
In July, after a court battle with FDA that started around mid-March when AstraZeneca Pharmaceuticals LP (“AstraZeneca”) sought to enjoin FDA from granting final ANDA approvals for generic SEROQUEL following FDA’s denial (without comment) of two citizen petitions AstraZeneca submitted to FDA last year concerning labeling carve-out issues, the U.S. [read post]
17 Jul 2012, 4:40 am
See AstraZeneca LP v. [read post]
9 Jul 2012, 7:41 pm
Karst – In a decision that, unless appealed, marks the end of AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) battle with FDA over the approval of generic versions of the company’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets, the U.S. [read post]
25 May 2012, 11:32 am
Judge Stark cited the Federal Circuit’s recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
24 May 2012, 4:23 am
Astrazeneca LP, 2010 WL 3706584, at *6 (Del. [read post]
16 May 2012, 12:22 pm
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352, 1360-66 (11th Cir. 2011) (plaintiff had not pleaded recoverable economic injury); Polk v. [read post]
20 Apr 2012, 10:36 am
McGrath In its recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
16 Apr 2012, 1:29 am
District Court are Motions for Summary Judgment filed by FDA and AstraZeneca Pharmaceuticals LP (here and here) concerning FDA’s approval of ANDAs for generic versions of SEROQUEL (quetiapine fumarate) Tablets and the Agency’s decision, discussed in a March 27, 2012 Letter Decision, concerning the scope and applicability of 3-year marketing exclusivity in that case. [read post]
29 Mar 2012, 5:47 am
District Court for the District of Columbia denied AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) Motion for Temporary Restraining Order (Complaint here) seeking to vacate FDA’s March 27, 2012 approval of more than 10 ANDAs for generic versions of AstraZeneca’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets (NDA No. 020639), and to enjoin FDA from granting any further final ANDA approvals for… [read post]
